Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Sirpa Leppa, Judit Joergensen, Anne Tierens, Ingunn Ostlie, Unn Merete Fagerli, Peter de Nully Brown, Thomas S. Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenholder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Bjorkholm, Oystein Fluge, Sirkku Jyrkkio, Elisabeth Ralfkiaer, Signe Spetalen, Marja-Liisa Karjalainen-Lindsberg, Harald Holte

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Issue number22
Number of pages6
Publication statusPublished - 2 Dec 2016
Event58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Canada
Duration: 3 Dec 20166 Dec 2016

Cite this